Barclays Starts PolyPid Ltd. (PYPD) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Raymond James Starts PolyPid Ltd. (PYPD) at Outperform
July 21, 2020 7:16 AM EDTRaymond James initiates coverage on PolyPid Ltd. (NASDAQ: PYPD) with a Outperform rating and a price target of $23.00.
For an analyst ratings summary and ratings history on PolyPid Ltd. click here. For more ratings news on PolyPid Ltd. click here.
Shares of PolyPid Ltd. closed at $15.61 yesterday.
... MoreBMO Capital Starts PolyPid Ltd. (PYPD) at Outperform
July 21, 2020 6:30 AM EDTBMO Capital analyst Gary Nachman initiates coverage on PolyPid Ltd. (NASDAQ: PYPD) with an Outperform rating and a price target of $30.00.
The analyst commented, "PYPDs proprietary PLEX technology has shown significant potential as a unique prolonged-release drug delivery platform for treating localized conditions. Lead... More
